Search for Clinical Trial Results

Sponsored By

Meningitis, Meningococcal - 23 Studies Found

Status Study
Completed Study Name: A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
Condition: Meningitis, Meningococcal
Date: 2007-05-16
Interventions:
  • Biological: Meningococcal ACWY Conjugate Vaccine

Completed Study Name: A Global Phase 3 Safety Study of 120 mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 Years
Condition: Meningitis, Meningococcal
Date: 2011-05-11
Interventions:
  • Biological: rLP2086 vaccine 12
Completed Study Name: Study Evaluating Safety And Tolerability Of Meningococcal B Rlp2086 Vaccine In Healthy Adults
Condition: Meningitis, Meningococcal
Date: 2009-04-10
Interventions: Biological: rLP2086 vaccine or control intra-muscular vaccine (solution), 0.5 mL, 3 doses, schedule: 0,
Completed Study Name: A Study Evaluating Safety And Immunogenicity Of Meningococcal B Rlp2086 Vaccine In Adolescents
Condition: Meningitis, Meningococcal
Date: 2008-12-12
Interventions:
  • Biological: meningococcal B rLP2086 vaccine.

Terminated Study Name: Study Evaluating Safety, Tolerability, and Immunogenicity of Meningococcal B Vaccine in Healthy Infants
Condition: Meningitis, Meningococcal
Date: 2008-11-25
Interventions:
  • Biological: meningococcal B rLP2086 vaccine

Completed Study Name: Safety And Blood Collection Study Of Meningococcal B Rlp2086 Vaccine In Adults
Condition: Meningitis, Meningococcal
Date: 2008-10-24
Interventions:
  • Biological: meningococcal B rLP2086 vaccine candidate

Completed Study Name: Study Evaluating the Tolerance of Conjugate Meningococcal C Vaccine in Infants
Condition: Meningitis, Meningococcal
Date: 2006-04-10
Interventions:
  • Biological: Meningococcal C
  • Biological: DT
Completed Study Name: Study Evaluating the Safety, Immunogenicity and Tolerability of Meningococcal Group B Vaccine in Healthy Adults
Condition: Meningitis, Meningococcal
Date: 2006-02-24
Interventions: Biological: MnB rLP2086
Completed Study Name: Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants
Condition: Meningitis, Meningococcal
Date: 2005-09-08
Interventions: Biological: Group C Meningococcal Polysaccharide-Tetanus Toxoid Conjugate Vaccine (GCMP-TT)
Completed Study Name: Safety and Blood Donations in Adults Vaccinated With rMenB+OMV NZ.
Condition: Meningitis, Meningococcal, Serogroup B
Date: 2014-11-20
Interventions: Biological: Meningococcal (group B) multicomponent recombinant adsorbed vaccine One dose (0.5 mL) vaccin
Next >>>